Biotechnology is the use of living organisms, biological processes or systems to manufacture/develop different drugs or products to improve the quality of life. The science of biotechnology is divided into four categories: red, white, green & blue.
Open Access eBooks is inviting researchers working in the areas of Biotechnology to submit their book chapter for the publication in volume 3 of an eBook ADVANCES IN BIOTECHNOLOGY.
All book chapters undergo review process and published content is available in PDF & HTML formats.
Universal Access: eBooks published in Open Access eBooks gain international visibility. No region barriers and content is accessed by everyone across the world from our website. We also deposit published eBooks in different databases.
Freely Available: Open Access eBooks follows the principles of Open Access and the content is available to the readers without any cost. Readers can read, share, and store the published ebooks/book chapters.
Copyright with Authors: As an eBook publisher, we serve researchers in publishing their valuable work after the stringent review process. However, copyright lies with authors. We follow the CC-BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/3.0/).
Different Formats: We provide eBooks in PDF and HTML formats. Both formats are user friendly and can act as per the user requirements. We put our efforts to provide other formats in future.
For more information, contact firstname.lastname@example.org
Cancer is a group of diseases involving abnormal cell division in an uncontrolled manner. Cancer affects almost all tissues; probably there are more than 200-250 types of cancer including breast cancer, ovarian cancer, skin cancer, leukemia etc. Different cell types in our body that can undergo the changes associated with cancer result in one or the other type of cancer .
The most urgent problem in the field of diabetology, and one of the most important challenges for the XXI century medicine, is to find cure for type 2 diabetes mellitus (T2D). It is estimated that the number of people with diabetes worldwide exceeds 200 million and most of them are T2D patients. In the industrialized world the prevalence of this disease has reached an epidemic proportion and is still growing . The adoption of a sedentary lifestyle, the consumption of non-traditional foods, and a genetic predisposition to the disease are thought to be the major underlying causes of the epidemic. In addition to the worrisome increase in the prevalence of diabetes mellitus (DM), the society at large will be further burdened with problems associated with various macro and microvascular complications of T2D.